<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>fonar99.TXT
<DESCRIPTION>FONAR EXHIBIT 99
<TEXT>
exhibit 99.1

================================================================================
================================================================================
                              FONAR CORPORATION

For Immediate Release                              FONAR Corporation NASDAQ-FONR

Contact:    Daniel  Culver                         110       Marcus        Drive
Director of Communications                         Melville,   New  York   11747
Web site:    www.fonar.com                         Telephone:   (631)   694-2929
Email:  investor@fonar.com                         Fax Number:  (631)   390-1709
================================================================================

     FONAR ANNOUNCES 1ST QUARTER FISCAL 2012 FINANCIAL RESULTS AS NET INCOME
                         INCREASES 360% TO $1.8 MILLION

MELVILLE,  NEW YORK,  November 14, 2011 - FONAR Corporation  (NASDAQ-FONR),  The
Inventor of MR  Scanning(TM),  reported  today its first quarter of fiscal 2012.
The  Company  reports  net income has risen 360% to $1.8  million  for the first
fiscal 2012 quarter ended September 30, 2011 from $363 thousand one year earlier
for the fiscal quarter ended  September 30, 2010. The Company has net income for
the past six quarters and income from operations for the past seven quarters.

Statement of Operations Items

Total revenues increased 11% to $9.6 million for the quarter ended September 30,
2011,  from $8.7  million  for the  corresponding  quarter  which ended one year
earlier on September 30, 2010.

The basic earnings per common share increased 257% to $0.25 per share during the
first  fiscal  quarter of fiscal 2012 as compared to $0.07 per common  share for
the first fiscal 2011 quarter ended September 30, 2010. In addition, the diluted
earnings  per common  share  increased  243% to $0.24 per share during the first
fiscal  quarter of fiscal  2012 as  compared  to $0.07 per common  share for the
first fiscal 2011 quarter ended September 30, 2010.

For the quarter  ended  September  30,  2011,  income from  operations  was $1.8
million.  This is compared to the same period ended September 30, 2010, when the
income from operations was $435 thousand.

Total operating costs and expenses  decreased 5% to $7.8 million for the quarter
ended  September 30, 2011 from $8.3 million for the quarter ended  September 30,
2010.

Revenues  from  product  sales were $1.8  million for the fiscal  quarter  ended
September  30, 2011 as compared to $2.7  million for the  corresponding  quarter
ended  September  30,  2010.  Revenues  from  service  and repair fees were $2.9
million  for the fiscal  quarter  ended  September  30, 2011 as compared to $2.7
million for the fiscal quarter ended September 30, 2010.

Revenues from the management and other fees segment (management of the ten FONAR
UPRIGHT(R)  Multi-Position(TM) MRI diagnostic imaging centers segment) increased
to $4.9 million for the fiscal  quarter  ended  September  30,  2011,  from $3.3
million for the fiscal quarter ended September 30, 2010.

Balance Sheet Items

As of September 30, 2011 total current assets were $24.5  million,  total assets
were $33.1 million,  total current  liabilities  were $23.1  million,  and total
long-term liabilities were $2.5 million.

As of  September  30,  2011,  total  cash and cash  equivalents  and  marketable
securities were $9.5 million as compared to $9.3 million as of June 30, 2011. In
addition,  this compares to $1.3 million for the fiscal quarter one year earlier
ended September 30, 2010.

As of  September  30,  2011,  the total  stockholder's  equity  improved to $7.5
million, as compared to a total stockholder's  equity of $5.9 million as of June
30, 2011.

Significant Quarter Highlight:

Breakthrough in the Diagnoses of Multiple Sclerosis

On September 20, 2011, a paper,  titled "The  Possible  Role of  Cranio-Cervical
Trauma and Abnormal CSF Hydrodynamics in the Genesis of Multiple Sclerosis," was
published  in the journal  Physiological  Chemistry  and Physics and Medical NMR
(Sept. 20, 2011, 41: 1-17). It was co-authored by FONAR MRI researchers  Raymond
V. Damadian, M.D., president and founder of FONAR and FONAR scientist David Chu,
PhD.

The journal article  reported a diagnostic  breakthrough  in multiple  sclerosis
(MS)  based  on  observations  made  possible  by  the  company's  unique  FONAR
UPRIGHT(R)  Multi-Position(TM)  MRI.  The  findings  reveal  that  the  cause of
multiple  sclerosis may be  biomechanical  and related to earlier  trauma to the
neck,  which can result in the  obstruction of the flow of  cerebrospinal  fluid
(CSF),  which is produced and stored in the central  anatomic  structures of the
brain known as the  ventricles.  Since the ventricles  produce a large volume of
CSF each day (500 cc),  an  obstruction  can  result  in a build up of  pressure
within the  ventricles,  resulting  in  leakage of the CSF into the  surrounding
brain tissue. This leakage could be responsible for generating the brain lesions
of multiple sclerosis.  The complete study in which the diagnostic  breakthrough
was reported can be viewed at http://www.fonar.com/pdf/PCP41_damadian.pdf.

Dr. Damadian said. "We used the UPRIGHT(R)  Multi-  Position(TM) MRI to view the
flow of  cerebrospinal  fluid in and out of the brain with the patients  scanned
UPRIGHT(R)  and scanned lying down.  The UPRIGHT(R) MRI also revealed that these
obstructions  were the result of structural  deformities of the cervical  spine,
induced  by trauma  earlier  in life.  The  findings  are based on  viewing  the
real-time  flow of  cerebrospinal  fluid in a series  of eight  randomly  chosen
patients with multiple  sclerosis.  These invaluable dual observations have only
been  possible  since the  invention  by FONAR of an MRI  capable of imaging the
patient UPRIGHT(R)."

The "Major Diagnostic  Breakthrough in Multiple Sclerosis Achieved With Advanced
UPRIGHT(R) MRI" was announced by Dr. Damadian on October 4, 2011, at a Radiology
Department  Grand  Rounds at the  University  of  California  San Diego  Medical
Center.

William G. Bradley,  Jr., M.D., Ph.D.,  F.A.C.R.,  Chairman of the Department of
Radiology,  and a Professor of  Radiology at UCSD School of Medicine  introduced
Dr. Damadian to his colleagues at grand rounds.  Dr. Bradley said, "Dr. Damadian
has shown that 8 patients  with MS had  degenerative  changes in their  cervical
spines which impinged on the spinal canal and limited the pulsatile,  to-and-fro
flow of cervical CSF over the cardiac cycle,  as demonstrated on UPRIGHT(R) MRI.
His  hypothesis  that  increased  resistance  to outflow of CSF is linked to the
etiology of MS has some  similarities to Dr. P. Zamboni's  hypothesis that MS is
due to the  impeded  outflow of venous  blood from the brain due to dural  sinus
stenoses.  In both  theories,  increased  resistance to outflow of either CSF or
venous blood would be expected to modify the intracranial pressure wave over the
cardiac  cycle.  While both  theories  need to be  further  tested  with  larger
controlled studies, it is intriguing that they seem to invoke similar pathologic
changes.  Whether  these  changes are etiologic in all cases of MS remains to be
tested."

Dr.  Damadian  stated,  "These new  observations  have  uncovered  biomechanical
barriers  that  appear  to give  rise to  multiple  sclerosis,  and,  even  more
excitingly,  these barriers may be therapeutically addressable. One of the eight
patients in the study, a 41-year-old female patient with MS was treated when her
symptoms subsided upon treatment."

FONAR reported on the case study on November 2, 2011.  The FONAR  UPRIGHT(R) MRI
found cervical malrotations at the cranio-cervical  junction,  which resulted in
alterations  of CSF flow  dynamics  and gave  rise to CSF  fluid  leakages  into
surrounding brain tissue. The CSF leakages visualized were directly connected to
MS lesions  visualized on the UPRIGHT(R) MRI. Following an Atlas Orthogonal (AO)
Correction by Dr. Scott Rosa, the patient experienced a significant reduction in
symptoms which correlate directly to 28.6% reduction of her CSF pressure on post
MRI evaluation.  The patient is currently  being  maintained free of MS symptoms
(vertigo  and  vomiting  on  recumbency)  by  weekly   treatments  with  the  AO
instrument.

Other Quarter Highlights

As  of  September  30,  2011,   FONAR  had   installed   152  FONAR   UPRIGHT(R)
Multi-Position(TM)  MRIs.  The 152nd was installed at the  Diagnostic  Radiology
Center of the Treasure Coast in Port St. Lucie, Florida.

A new California customer purchased the FONAR UPRIGHT(R)  Multi-Position(TM) MRI
saying it was because of their  dedication to being a `center of excellence  for
the spine'.  One of the  physicians,  Hoorman M.  Melamed,  MD,  FAOOS,  a board
certified  orthopaedic  spine  surgeon,  and  a  principal  at  the  Bakersfield
UPRIGHT(R)   MRI   Center,   said,    "Selection   of   the   FONAR   UPRIGHT(R)
Multi-Position(TM) MRI for our group was a very careful and deliberate decision.
We  recognize  that the  UPRIGHT(R)  MRI offers  capabilities  beyond  that of a
recumbent-only  MRI. The  UPRIGHT(R)  MRI allows for scanning  patients  weight-
bearing and in the dynamic positions of flexion and extension. This allows us to
see and evaluate the patient's  spine  pathology under load and thus enabling us
to avoid  underestimating a patient's pathology and therefore obtaining a better
diagnosis."

Another  new  customer  for the FONAR  UPRIGHT(R)  Multi-Position(TM)  MRI was a
physician  practice of radiologists and  neurosurgeons  located in the Northeast
section  of the  U.S.  It will be part of a  newly-constructed  75,000  sq.  ft.
state-of-the-art  neuroscience  spine institute where it will be the hallmark of
their goal of becoming a center of excellence in spine care.

Management Commentary

Dr.  Damadian  said,  "Over the last six  quarters  we have a net profit of $4.9
million.  This is due to changes  that we have had to make  including a focus on
the management of our ten UPRIGHT(R) MRI imaging centers and some difficult cost
reductions. While sales are not as robust as in prior years, we believe sales of
the  UPRIGHT(R)  Multi-Position(TM)  MRI  will  increase  as  the  U.S.  economy
continues its  recovery.  This is because the  UPRIGHT(R)  MRI has huge value in
medicine when it comes to diagnosing  the spine.  As time goes on, more and more
physicians and patients  recognize  this. The discovery that an interrupted  CSF
flow causes MS is a valuable  discovery and one that will  immensely  help those
poor souls afflicted with the symptoms of MS as well as FONAR tremendously."

About FONAR

FONAR  (NASDAQ:FONR),  Melville,  NY,  The  Inventor  of  MR  Scanning(TM),  was
incorporated in 1978, and is the first,  oldest and most experienced MRI company
in the industry.  FONAR introduced the world's first commercial MRI in 1980, and
went public in 1981. Since its inception, nearly 300 recumbent-OPEN MRIs and 150
UPRIGHT(R)  Multi-Position(TM)  MRI  scanners  have  been  installed  worldwide.
FONAR's  stellar  product is the UPRIGHT(R)  MRI (also known as the  Stand-Up(R)
MRI), the only whole-body MRI that performs  Position(TM) imaging (pMRI(TM)) and
scans patients in numerous weight-bearing positions, i.e. standing,  sitting, in
flexion and extension, as well as the conventional lie- down position. The FONAR
UPRIGHT(R)  MRI often sees the  patient's  problem  that other  scanners  cannot
because  they are lie-down  only.  The patient-  friendly  UPRIGHT(R)  MRI has a
near-zero claustrophobic rejection rate by patients. As a FONAR customer states,
"If the patient is claustrophobic in this scanner,  they'll be claustrophobic in
my parking lot."  Approximately  85% of patients are scanned  sitting while they
watch a 42" flat screen TV. FONAR is headquartered on Long Island, New York.

                                       #

UPRIGHT(R)  and  STAND-UP(R)  are  registered  trademarks and The Inventor of MR
Scanning(TM),   Full   Range   of   Motion(TM),   Multi-Position(TM),    Upright
Radiology(TM),  The  Proof  is in  the  Picture(TM),  True  Flow(TM),  pMRI(TM),
Spondylography(TM),  Dynamic(TM), Spondylometry(TM), CSP(TM), and Landscape(TM),
are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or
may not materialize.  Additional  information on factors that could  potentially
affect the company's  financial  results may be found in the  company's  filings
with the Securities and Exchange Commission.


<PAGE>
                       FONAR CORPORATION AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (000's OMITTED)


ASSETS                                                   September 30,  June 30,
                                                                2011      2011
                                                           (UNAUDITED)
Current Assets:                                            -----------  --------
  Cash and cash equivalents                                   $ 9,512   $ 9,251

  Marketable securities                                            28        33

  Accounts receivable - net                                     4,701     5,264

  Accounts receivable - related party                              90      -

  Management and other fees receivable - net                    3,496     3,309

  Management and other fees receivable - related
    medical practices - net                                     1,714     1,669

  Costs and estimated earnings in excess of
    billings on uncompleted contracts                             557       169

  Inventories                                                   3,817     2,400

  Current portion of notes receivable - net                       114       114

  Prepaid expenses and other current assets                       425       352
                                                              -------   -------
        Total Current Assets                                   24,454    22,561
                                                              -------   -------

Property and equipment - net                                    3,499     3,769

Notes receivable                                                  344       359

Other intangible assets - net                                   4,219     4,318

Other assets                                                      587       574
                                                              --------  --------
        Total Assets                                          $33,103   $31,581
                                                              ========  ========


<PAGE>
                       FONAR CORPORATION AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (000's OMITTED)


                                                        September 30,   June 30,
LIABILITIES AND STOCKHOLDERS' EQUITY                          2011        2011
                                                           (UNAUDITED)
Current Liabilities:                                       -----------  --------
  Current portion of long-term debt and capital leases        $ 1,818   $ 2,026
  Accounts payable                                              2,074     2,187
  Other current liabilities                                     9,264     8,236
  Unearned revenue on service contracts                         5,379     5,762
  Unearned revenue on service contracts - related party            82      -
  Customer advances                                             3,638     4,846
  Billings in excess of costs and estimated
    earnings on uncompleted contracts                             817         4
  Income tax payable                                               75        75
                                                               ------    ------
      Total Current Liabilities                                23,147    23,136

Long-Term Liabilities:
  Accounts payable                                                148       102
  Due to related medical practices                                230       228
  Long-term debt and capital leases,
    less current portion                                        1,628     1,746
  Other liabilities                                               498       502
                                                               ------    ------
      Total Long-Term Liabilities                               2,504     2,578
                                                               ------    ------
      Total Liabilities                                        25,651    25,714
                                                               ------    ------



<PAGE>
                      FONAR CORPORATION AND SUBSIDIARIES
                     CONDENSED CONSOLIDATED BALANCE SHEETS
                      (000's OMITTED, except share data)


                                                         September 30,  June 30,
LIABILITIES AND STOCKHOLDERS' EQUITY                          2011        2011
  (continued)                                              (UNAUDITED)
                                                            ----------  --------
STOCKHOLDERS' EQUITY:

Class A non-voting preferred stock $.0001 par value;
453,000 shares authorized at
September 30, 2011 and June 30, 2011,
313,451 issued and outstanding
at September 30, 2011 and June 30, 2011                         -          -

Preferred stock $.001 par value; 567,000
shares authorized at September 30, 2011
and June 30, 2011,
issued and outstanding - none                                   -          -

Common Stock $.0001 par value; 8,500,000 shares
authorized at September 30, 2011 and June 30, 2011,
5,689,171 and 5,636,571 issued at
September 30, 2011 and June 30, 2011, respectively;
5,677,528 and 5,624,928 outstanding at September 30, 2011
and June 30, 2011, respectively                                     1         1

Class B Common Stock (10 votes per share)
$ .0001 par value; 227,000 shares
authorized at September 30, 2011 and
June 30, 2011; 158 issued and
outstanding at September 30, 2011 and June 30, 2011              -         -

Class C Common Stock (25 votes per share)
$.0001 par value; 567,000 shares
authorized at September 30, 2011 and June 30, 2011,
382,513 issued and outstanding
at September 30, 2011 and June 30, 2011                          -         -

Paid-in capital in excess of par value                        173,580   173,476
Accumulated other comprehensive loss                              (22)      (16)
Accumulated deficit                                          (172,597) (174,110)
Notes receivable from employee stockholders                      (113)     (115)
Treasury stock, at cost - 11,643 shares of common stock
  at September 30, 2011 and June 30, 2011                        (675)     (675)
Non controlling interests                                       7,278     7,306
                                                              --------  --------
      Total Stockholders' Equity                                7,452     5,867
                                                              --------  --------
      Total Liabilities and Stockholders' Equity              $33,103   $31,581
                                                              ========  ========



<PAGE>
                      FONAR CORPORATION AND SUBSIDIARIES
            CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
                    (000's OMITTED, except per share data)

                                                      FOR THE THREE MONTHS ENDED
                                                                 SEPTEMBER 30,
                                                              ------------------
                                                                2011      2010
REVENUES                                                      --------  --------
  Product sales - net                                         $ 1,776   $ 2,660
  Service and repair fees - net                                 2,905     2,689
  Service and repair fees - related parties - net                  27        55
  Management and other fees - net                               3,329     2,088
  Management and other fees - related medical
    practices - net                                             1,571     1,193
                                                              --------  --------
     Total Revenues - Net                                       9,608     8,685
                                                              --------  --------
COSTS AND EXPENSES
  Costs related to product sales                                1,475     2,506
  Costs related to service and repair fees                        813       665
  Costs related to service and repair
    fees - related parties                                          8        14
  Costs related to management and other fees                    2,185     1,313
  Costs related to management and other
    fees - related medical practices                              819       739
  Research and development                                        329       454
  Selling, general and administrative                           2,043     2,383
  Provision for bad debts                                         175       176
                                                              --------  --------
     Total Costs and Expenses                                   7,847     8,250
                                                              --------  --------
Income From Operations                                          1,761       435

Interest Expense                                                 (107)      (94)
Interest Expense - Related Parties                                  -        (4)
Investment Income                                                  62        38
Interest Income - Related Party                                     -         1
Other Income                                                       56         9
                                                              --------  --------
Net Income                                                      1,772       385
Net Income - Non Controlling Interests                           (259)     -
                                                              --------  --------
Net Income - Controlling Interests                            $ 1,513   $   385
                                                              ========  ========
Net Income Available to Common Stockholders                   $ 1,409   $   363
                                                              ========  ========
Net Income Available to Class A Non-Voting
  Preferred Stockholders                                      $    78   $    22
                                                              ========  ========
Net Income Available to Class C Common Stockholders           $    27   $     7
                                                              ========  ========
Basic Net Income Per Common Share Available
  to Common Stockholders                                      $  0.25   $  0.07
                                                              ========  ========
Diluted Net Income Per Common Share Available
  to Common Stockholders                                     $   0.24   $   0.07
                                                              ========  ========
Basic and Diluted Income Per Share - Common C                $   0.07   $   0.02
                                                              ========  ========
Weighted Average Basic Shares Outstanding                    5,668,762 5,012,245
                                                             ========= =========
Weighted Average Diluted Shares Outstanding                  5,796,266 5,139,749
                                                             ========= =========

</TEXT>
</DOCUMENT>
